Jacobs Solutions Inc. logo

Jacobs Solutions Inc. (J)

Market Closed
1 Sep, 20:00
NYSE NYSE
$
146. 33
-2.72
-1.8249%
$
17.6B Market Cap
- P/E Ratio
2.64% Div Yield
926,125 Volume
- Eps
$ 149.05
Previous Close
Add Transaction
Day Range
146.06 149.8
Year Range
105.68 168.44
Want to track J and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jacobs Wins 10-Year Contract for Advanced Water Purification Project

Jacobs Wins 10-Year Contract for Advanced Water Purification Project

J secures a key contract with Soquel Creek Water District to drive water sustainability.

Zacks | 1 year ago
Jacobs Enters Into a Contract With DESNZ for the CCUS Program

Jacobs Enters Into a Contract With DESNZ for the CCUS Program

J stock is set to benefit from a boost in the backlog, thanks to the CCUS program from DESNZ.

Zacks | 1 year ago
Jacobs Wins 5-Year California Wastewater Infrastructure Contract

Jacobs Wins 5-Year California Wastewater Infrastructure Contract

J's digital and data-driven solutions are set to strengthen water and wastewater services in California to drive efficiency.

Zacks | 1 year ago
Why Jacobs Solutions (J) is a Top Momentum Stock for the Long-Term

Why Jacobs Solutions (J) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Jacobs Chosen to Manage $227M LIRR Station ADA Upgrade Project

Jacobs Chosen to Manage $227M LIRR Station ADA Upgrade Project

J is set to manage the $227M project to enhance ADA compliance and commuter experience.

Zacks | 1 year ago
Here's Why Jacobs Solutions (J) is a Strong Growth Stock

Here's Why Jacobs Solutions (J) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Jacobs Solutions (J) is a Top-Ranked Value Stock: Should You Buy?

Jacobs Solutions (J) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Why Is Jacobs Solutions (J) Up 5.3% Since Last Earnings Report?

Why Is Jacobs Solutions (J) Up 5.3% Since Last Earnings Report?

Jacobs Solutions (J) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Jacobs Solutions Q3: Strong Backlog Supports Growth For FY25

Jacobs Solutions Q3: Strong Backlog Supports Growth For FY25

Jacobs Solutions shows strong backlog growth and is nearing completion of a spin-off and merger, reinforcing my ‘Strong Buy' rating with a $170 price target. The spin-off of Critical Mission Solutions and Cyber & Intelligence Businesses will allow J stock to focus on high-margin critical infrastructure and sustainability projects. Jacobs delivered 1% revenue growth and 5.9% backlog growth in Q3, with strong future growth expected in the People and Places Solutions and PA consulting segments.

Seekingalpha | 1 year ago
Why Jacobs Solutions (J) is a Top Growth Stock for the Long-Term

Why Jacobs Solutions (J) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Here's Why Jacobs Solutions (J) is a Strong Value Stock

Here's Why Jacobs Solutions (J) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock

If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock

Jacobs Solutions is a specialty manufacturing company operating across a variety of growth markets. Jacobs works closely with Eli Lilly, the pharmaceutical giant behind diabetes and chronic weight management medications Mounjaro and Zepbound.

Fool | 2 years ago
Loading...
Load More